BioSpace News Archive

Generex Announces Upgrade to OTCQB Venture Market

The company announced that trading in its common stock will be upgraded to the OTCQB® Venture Market on November 30, 2017 after a successful application to up-list from the OTC Pink Market.

November 30, 2017
·
2 min read
Business

BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

The study is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated “Apple Heart Study” App.

November 30, 2017
·
1 min read
Scythian Biosciences Completes Sale of Go Green

In addition to the cash compensation received, 27,000 common shares of Scythian are being returned to treasury for cancellation.

November 30, 2017
·
3 min read
Verona Pharma: PDMR Dealing

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

November 30, 2017
·
1 min read
Business

OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing

OraSure is working with The AIDS Institute to launch a grant program to encourage the development of innovative HIV self testing programs and collaborating with both The AIDS Institute and Walgreens to promote rapid HIV testing in cities across the U.S.

November 30, 2017
·
6 min read
ALK Secures Pricing and Reimbursement for ACARIZAX in France

A marketing authorisation for France was first granted in January 2016 and since then, ALK has been in dialogue with the authorities to secure market access for the product.

November 30, 2017
·
2 min read
BioCapital

Emergent BioSolutions to Host 2017 Analyst & Investor Day

This event, which is designed for sellside research analysts and institutional investors, will take place at The Westin New York at Times Square, 270 West 43rd Street, New York, New York 10036.

November 30, 2017
·
2 min read
BioCapital

K2M Announces Completion of 300 RHINE Cervical Disc System Surgical Cases

K2M to feature its RHINE Cervical Disc System, industry-leading 3D-printed portfolio, & Balance ACS® Platform at the 2017 Meeting of the German Spine Society.

November 30, 2017
·
10 min read
Business

Probiodrug Reports Third Quarter 2017 Business Update

The interim management report for the third quarter 2017 is available to download on the company’s website.

November 30, 2017
·
16 min read
Business

MorphoSys Signs Regional License Agreement for Antibody MOR202 With I-Mab

MorphoSys to receive a USD 20 million upfront payment and entitled to tiered, double digit royalties on net sales of MOR202 plus milestone payments of up to USD 100 million from I-Mab

November 30, 2017
·
6 min read